Medical Care
Global Central Nervous System (CNS) Therapeutic Market Research Report 2025
- Sep 09, 25
- ID: 494640
- Pages: 74
- Figures: 72
- Views: 17
This report aims to provide a comprehensive presentation of the global market for Central Nervous System (CNS) Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Central Nervous System (CNS) Therapeutic.
The Central Nervous System (CNS) Therapeutic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Central Nervous System (CNS) Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Central Nervous System (CNS) Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Biogen
Johnson & Johnson
Eli Lilly
Otsuka America Pharmaceutical
Merck
Astrazeneca
Novartis
Teva Pharmaceutical Industries
Takeda
Segment by Type
Neurovascular
Trauma
Mental Health
Degenerative Disorder
Infections
Cancer
Segment by Application
Clinical Application
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Central Nervous System (CNS) Therapeutic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Central Nervous System (CNS) Therapeutic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Central Nervous System (CNS) Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Central Nervous System (CNS) Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Biogen
Johnson & Johnson
Eli Lilly
Otsuka America Pharmaceutical
Merck
Astrazeneca
Novartis
Teva Pharmaceutical Industries
Takeda
Segment by Type
Neurovascular
Trauma
Mental Health
Degenerative Disorder
Infections
Cancer
Segment by Application
Clinical Application
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Central Nervous System (CNS) Therapeutic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Neurovascular
1.2.3 Trauma
1.2.4 Mental Health
1.2.5 Degenerative Disorder
1.2.6 Infections
1.2.7 Cancer
1.3 Market by Application
1.3.1 Global Central Nervous System (CNS) Therapeutic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Application
1.3.3 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Therapeutic Market Perspective (2020-2031)
2.2 Global Central Nervous System (CNS) Therapeutic Growth Trends by Region
2.2.1 Global Central Nervous System (CNS) Therapeutic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Central Nervous System (CNS) Therapeutic Historic Market Size by Region (2020-2025)
2.2.3 Central Nervous System (CNS) Therapeutic Forecasted Market Size by Region (2026-2031)
2.3 Central Nervous System (CNS) Therapeutic Market Dynamics
2.3.1 Central Nervous System (CNS) Therapeutic Industry Trends
2.3.2 Central Nervous System (CNS) Therapeutic Market Drivers
2.3.3 Central Nervous System (CNS) Therapeutic Market Challenges
2.3.4 Central Nervous System (CNS) Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue
3.1.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue (2020-2025)
3.1.2 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Players (2020-2025)
3.2 Global Central Nervous System (CNS) Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Central Nervous System (CNS) Therapeutic Revenue
3.4 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio
3.4.1 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Therapeutic Revenue in 2024
3.5 Global Key Players of Central Nervous System (CNS) Therapeutic Head office and Area Served
3.6 Global Key Players of Central Nervous System (CNS) Therapeutic, Product and Application
3.7 Global Key Players of Central Nervous System (CNS) Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Central Nervous System (CNS) Therapeutic Breakdown Data by Type
4.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Type (2020-2025)
4.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2026-2031)
5 Central Nervous System (CNS) Therapeutic Breakdown Data by Application
5.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Application (2020-2025)
5.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Central Nervous System (CNS) Therapeutic Market Size (2020-2031)
6.2 North America Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025)
6.4 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Central Nervous System (CNS) Therapeutic Market Size (2020-2031)
7.2 Europe Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025)
7.4 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size (2020-2031)
8.2 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2020-2025)
8.4 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Central Nervous System (CNS) Therapeutic Market Size (2020-2031)
9.2 Latin America Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025)
9.4 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size (2020-2031)
10.2 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025)
10.4 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Central Nervous System (CNS) Therapeutic Introduction
11.1.4 Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Central Nervous System (CNS) Therapeutic Introduction
11.2.4 Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.2.5 Biogen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Central Nervous System (CNS) Therapeutic Introduction
11.3.4 Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Central Nervous System (CNS) Therapeutic Introduction
11.4.4 Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.4.5 Eli Lilly Recent Development
11.5 Otsuka America Pharmaceutical
11.5.1 Otsuka America Pharmaceutical Company Details
11.5.2 Otsuka America Pharmaceutical Business Overview
11.5.3 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Introduction
11.5.4 Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.5.5 Otsuka America Pharmaceutical Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Central Nervous System (CNS) Therapeutic Introduction
11.6.4 Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.6.5 Merck Recent Development
11.7 Astrazeneca
11.7.1 Astrazeneca Company Details
11.7.2 Astrazeneca Business Overview
11.7.3 Astrazeneca Central Nervous System (CNS) Therapeutic Introduction
11.7.4 Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.7.5 Astrazeneca Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Central Nervous System (CNS) Therapeutic Introduction
11.8.4 Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.8.5 Novartis Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Central Nervous System (CNS) Therapeutic Introduction
11.10.4 Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.10.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Neurovascular
1.2.3 Trauma
1.2.4 Mental Health
1.2.5 Degenerative Disorder
1.2.6 Infections
1.2.7 Cancer
1.3 Market by Application
1.3.1 Global Central Nervous System (CNS) Therapeutic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Application
1.3.3 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Therapeutic Market Perspective (2020-2031)
2.2 Global Central Nervous System (CNS) Therapeutic Growth Trends by Region
2.2.1 Global Central Nervous System (CNS) Therapeutic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Central Nervous System (CNS) Therapeutic Historic Market Size by Region (2020-2025)
2.2.3 Central Nervous System (CNS) Therapeutic Forecasted Market Size by Region (2026-2031)
2.3 Central Nervous System (CNS) Therapeutic Market Dynamics
2.3.1 Central Nervous System (CNS) Therapeutic Industry Trends
2.3.2 Central Nervous System (CNS) Therapeutic Market Drivers
2.3.3 Central Nervous System (CNS) Therapeutic Market Challenges
2.3.4 Central Nervous System (CNS) Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue
3.1.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue (2020-2025)
3.1.2 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Players (2020-2025)
3.2 Global Central Nervous System (CNS) Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Central Nervous System (CNS) Therapeutic Revenue
3.4 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio
3.4.1 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Therapeutic Revenue in 2024
3.5 Global Key Players of Central Nervous System (CNS) Therapeutic Head office and Area Served
3.6 Global Key Players of Central Nervous System (CNS) Therapeutic, Product and Application
3.7 Global Key Players of Central Nervous System (CNS) Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Central Nervous System (CNS) Therapeutic Breakdown Data by Type
4.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Type (2020-2025)
4.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2026-2031)
5 Central Nervous System (CNS) Therapeutic Breakdown Data by Application
5.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Application (2020-2025)
5.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Central Nervous System (CNS) Therapeutic Market Size (2020-2031)
6.2 North America Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025)
6.4 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Central Nervous System (CNS) Therapeutic Market Size (2020-2031)
7.2 Europe Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025)
7.4 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size (2020-2031)
8.2 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2020-2025)
8.4 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Central Nervous System (CNS) Therapeutic Market Size (2020-2031)
9.2 Latin America Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025)
9.4 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size (2020-2031)
10.2 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025)
10.4 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Central Nervous System (CNS) Therapeutic Introduction
11.1.4 Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Central Nervous System (CNS) Therapeutic Introduction
11.2.4 Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.2.5 Biogen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Central Nervous System (CNS) Therapeutic Introduction
11.3.4 Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Central Nervous System (CNS) Therapeutic Introduction
11.4.4 Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.4.5 Eli Lilly Recent Development
11.5 Otsuka America Pharmaceutical
11.5.1 Otsuka America Pharmaceutical Company Details
11.5.2 Otsuka America Pharmaceutical Business Overview
11.5.3 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Introduction
11.5.4 Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.5.5 Otsuka America Pharmaceutical Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Central Nervous System (CNS) Therapeutic Introduction
11.6.4 Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.6.5 Merck Recent Development
11.7 Astrazeneca
11.7.1 Astrazeneca Company Details
11.7.2 Astrazeneca Business Overview
11.7.3 Astrazeneca Central Nervous System (CNS) Therapeutic Introduction
11.7.4 Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.7.5 Astrazeneca Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Central Nervous System (CNS) Therapeutic Introduction
11.8.4 Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.8.5 Novartis Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Central Nervous System (CNS) Therapeutic Introduction
11.10.4 Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025)
11.10.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Neurovascular
Table 3. Key Players of Trauma
Table 4. Key Players of Mental Health
Table 5. Key Players of Degenerative Disorder
Table 6. Key Players of Infections
Table 7. Key Players of Cancer
Table 8. Global Central Nervous System (CNS) Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Central Nervous System (CNS) Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Central Nervous System (CNS) Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Central Nervous System (CNS) Therapeutic Market Share by Region (2020-2025)
Table 12. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Central Nervous System (CNS) Therapeutic Market Share by Region (2026-2031)
Table 14. Central Nervous System (CNS) Therapeutic Market Trends
Table 15. Central Nervous System (CNS) Therapeutic Market Drivers
Table 16. Central Nervous System (CNS) Therapeutic Market Challenges
Table 17. Central Nervous System (CNS) Therapeutic Market Restraints
Table 18. Global Central Nervous System (CNS) Therapeutic Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Central Nervous System (CNS) Therapeutic Market Share by Players (2020-2025)
Table 20. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2024)
Table 21. Ranking of Global Top Central Nervous System (CNS) Therapeutic Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Central Nervous System (CNS) Therapeutic Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Central Nervous System (CNS) Therapeutic, Headquarters and Area Served
Table 24. Global Key Players of Central Nervous System (CNS) Therapeutic, Product and Application
Table 25. Global Key Players of Central Nervous System (CNS) Therapeutic, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Central Nervous System (CNS) Therapeutic Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2020-2025)
Table 29. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2026-2031)
Table 31. Global Central Nervous System (CNS) Therapeutic Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Application (2020-2025)
Table 33. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Application (2026-2031)
Table 35. North America Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 50. Pfizer Company Details
Table 51. Pfizer Business Overview
Table 52. Pfizer Central Nervous System (CNS) Therapeutic Product
Table 53. Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. Biogen Company Details
Table 56. Biogen Business Overview
Table 57. Biogen Central Nervous System (CNS) Therapeutic Product
Table 58. Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 59. Biogen Recent Development
Table 60. Johnson & Johnson Company Details
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Central Nervous System (CNS) Therapeutic Product
Table 63. Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 64. Johnson & Johnson Recent Development
Table 65. Eli Lilly Company Details
Table 66. Eli Lilly Business Overview
Table 67. Eli Lilly Central Nervous System (CNS) Therapeutic Product
Table 68. Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 69. Eli Lilly Recent Development
Table 70. Otsuka America Pharmaceutical Company Details
Table 71. Otsuka America Pharmaceutical Business Overview
Table 72. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Product
Table 73. Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 74. Otsuka America Pharmaceutical Recent Development
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Central Nervous System (CNS) Therapeutic Product
Table 78. Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 79. Merck Recent Development
Table 80. Astrazeneca Company Details
Table 81. Astrazeneca Business Overview
Table 82. Astrazeneca Central Nervous System (CNS) Therapeutic Product
Table 83. Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 84. Astrazeneca Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Central Nervous System (CNS) Therapeutic Product
Table 88. Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 89. Novartis Recent Development
Table 90. Teva Pharmaceutical Industries Company Details
Table 91. Teva Pharmaceutical Industries Business Overview
Table 92. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Product
Table 93. Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 94. Teva Pharmaceutical Industries Recent Development
Table 95. Takeda Company Details
Table 96. Takeda Business Overview
Table 97. Takeda Central Nervous System (CNS) Therapeutic Product
Table 98. Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 99. Takeda Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Central Nervous System (CNS) Therapeutic Picture
Figure 2. Global Central Nervous System (CNS) Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Central Nervous System (CNS) Therapeutic Market Share by Type: 2024 VS 2031
Figure 4. Neurovascular Features
Figure 5. Trauma Features
Figure 6. Mental Health Features
Figure 7. Degenerative Disorder Features
Figure 8. Infections Features
Figure 9. Cancer Features
Figure 10. Global Central Nervous System (CNS) Therapeutic Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Central Nervous System (CNS) Therapeutic Market Share by Application: 2024 VS 2031
Figure 12. Clinical Application Case Studies
Figure 13. Others Case Studies
Figure 14. Central Nervous System (CNS) Therapeutic Report Years Considered
Figure 15. Global Central Nervous System (CNS) Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Central Nervous System (CNS) Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Central Nervous System (CNS) Therapeutic Market Share by Region: 2024 VS 2031
Figure 18. Global Central Nervous System (CNS) Therapeutic Market Share by Players in 2024
Figure 19. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Therapeutic Revenue in 2024
Figure 21. North America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Central Nervous System (CNS) Therapeutic Market Share by Country (2020-2031)
Figure 23. United States Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Central Nervous System (CNS) Therapeutic Market Share by Country (2020-2031)
Figure 27. Germany Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Share by Region (2020-2031)
Figure 35. China Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Central Nervous System (CNS) Therapeutic Market Share by Country (2020-2031)
Figure 43. Mexico Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Share by Country (2020-2031)
Figure 47. Turkey Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Pfizer Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 51. Biogen Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 52. Johnson & Johnson Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 53. Eli Lilly Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 54. Otsuka America Pharmaceutical Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 56. Astrazeneca Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 57. Novartis Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 58. Teva Pharmaceutical Industries Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 59. Takeda Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Neurovascular
Table 3. Key Players of Trauma
Table 4. Key Players of Mental Health
Table 5. Key Players of Degenerative Disorder
Table 6. Key Players of Infections
Table 7. Key Players of Cancer
Table 8. Global Central Nervous System (CNS) Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Central Nervous System (CNS) Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Central Nervous System (CNS) Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Central Nervous System (CNS) Therapeutic Market Share by Region (2020-2025)
Table 12. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Central Nervous System (CNS) Therapeutic Market Share by Region (2026-2031)
Table 14. Central Nervous System (CNS) Therapeutic Market Trends
Table 15. Central Nervous System (CNS) Therapeutic Market Drivers
Table 16. Central Nervous System (CNS) Therapeutic Market Challenges
Table 17. Central Nervous System (CNS) Therapeutic Market Restraints
Table 18. Global Central Nervous System (CNS) Therapeutic Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Central Nervous System (CNS) Therapeutic Market Share by Players (2020-2025)
Table 20. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2024)
Table 21. Ranking of Global Top Central Nervous System (CNS) Therapeutic Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Central Nervous System (CNS) Therapeutic Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Central Nervous System (CNS) Therapeutic, Headquarters and Area Served
Table 24. Global Key Players of Central Nervous System (CNS) Therapeutic, Product and Application
Table 25. Global Key Players of Central Nervous System (CNS) Therapeutic, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Central Nervous System (CNS) Therapeutic Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2020-2025)
Table 29. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2026-2031)
Table 31. Global Central Nervous System (CNS) Therapeutic Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Application (2020-2025)
Table 33. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Application (2026-2031)
Table 35. North America Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 50. Pfizer Company Details
Table 51. Pfizer Business Overview
Table 52. Pfizer Central Nervous System (CNS) Therapeutic Product
Table 53. Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. Biogen Company Details
Table 56. Biogen Business Overview
Table 57. Biogen Central Nervous System (CNS) Therapeutic Product
Table 58. Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 59. Biogen Recent Development
Table 60. Johnson & Johnson Company Details
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Central Nervous System (CNS) Therapeutic Product
Table 63. Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 64. Johnson & Johnson Recent Development
Table 65. Eli Lilly Company Details
Table 66. Eli Lilly Business Overview
Table 67. Eli Lilly Central Nervous System (CNS) Therapeutic Product
Table 68. Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 69. Eli Lilly Recent Development
Table 70. Otsuka America Pharmaceutical Company Details
Table 71. Otsuka America Pharmaceutical Business Overview
Table 72. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Product
Table 73. Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 74. Otsuka America Pharmaceutical Recent Development
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Central Nervous System (CNS) Therapeutic Product
Table 78. Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 79. Merck Recent Development
Table 80. Astrazeneca Company Details
Table 81. Astrazeneca Business Overview
Table 82. Astrazeneca Central Nervous System (CNS) Therapeutic Product
Table 83. Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 84. Astrazeneca Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Central Nervous System (CNS) Therapeutic Product
Table 88. Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 89. Novartis Recent Development
Table 90. Teva Pharmaceutical Industries Company Details
Table 91. Teva Pharmaceutical Industries Business Overview
Table 92. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Product
Table 93. Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 94. Teva Pharmaceutical Industries Recent Development
Table 95. Takeda Company Details
Table 96. Takeda Business Overview
Table 97. Takeda Central Nervous System (CNS) Therapeutic Product
Table 98. Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2020-2025) & (US$ Million)
Table 99. Takeda Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Central Nervous System (CNS) Therapeutic Picture
Figure 2. Global Central Nervous System (CNS) Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Central Nervous System (CNS) Therapeutic Market Share by Type: 2024 VS 2031
Figure 4. Neurovascular Features
Figure 5. Trauma Features
Figure 6. Mental Health Features
Figure 7. Degenerative Disorder Features
Figure 8. Infections Features
Figure 9. Cancer Features
Figure 10. Global Central Nervous System (CNS) Therapeutic Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Central Nervous System (CNS) Therapeutic Market Share by Application: 2024 VS 2031
Figure 12. Clinical Application Case Studies
Figure 13. Others Case Studies
Figure 14. Central Nervous System (CNS) Therapeutic Report Years Considered
Figure 15. Global Central Nervous System (CNS) Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Central Nervous System (CNS) Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Central Nervous System (CNS) Therapeutic Market Share by Region: 2024 VS 2031
Figure 18. Global Central Nervous System (CNS) Therapeutic Market Share by Players in 2024
Figure 19. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Therapeutic Revenue in 2024
Figure 21. North America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Central Nervous System (CNS) Therapeutic Market Share by Country (2020-2031)
Figure 23. United States Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Central Nervous System (CNS) Therapeutic Market Share by Country (2020-2031)
Figure 27. Germany Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Share by Region (2020-2031)
Figure 35. China Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Central Nervous System (CNS) Therapeutic Market Share by Country (2020-2031)
Figure 43. Mexico Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Share by Country (2020-2031)
Figure 47. Turkey Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Pfizer Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 51. Biogen Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 52. Johnson & Johnson Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 53. Eli Lilly Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 54. Otsuka America Pharmaceutical Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 56. Astrazeneca Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 57. Novartis Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 58. Teva Pharmaceutical Industries Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 59. Takeda Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232